Alessandro Agnarelli

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsGenome structure and regulationPredictive and prognostic markersMedical infection agents (incl. prions)Cell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2026
A Regulatory Element in the Intrinsically Disordered C-Terminal Region of LMTK3 Modulates Its Kinase Domain Interactions and Breast Cancer Phenotypes.

|Jun 05, 2026
Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors.

|Dec 03, 2025
The genetic and biochemical basis of human leading strand synthesis.

Alessandro Agnarelli, Lauryn Buckley-Benbow, Meryem Ozgencil

|Jan 08, 2023
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.

Alessandro Agnarelli, Andrea Lauer Betrán, Athanasios Papakyriakou

|Sep 23, 2022
Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications.

Alessandro Agnarelli, Viviana Vella, Mark Samuels

|May 11, 2022
Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.

Alessandro Agnarelli, Simon Mitchell, Gillian Caalim

Pageof 2

Frequent Collaborators

3 joint publications

Erika J Mancini

3 joint publications

Georgios Giamas

2 joint publications

Viviana Vella

2 joint publications

Roberto Bellelli